Currently, there are 95.08M common shares owned by the public and among those 93.11M shares have been available to trade.
The company’s stock has a 5-day price change of -1.92% and -22.48% over the past three months. THC shares are trading 72.03% year to date (YTD), with the 12-month market performance up to 71.62% higher. It has a 12-month low price of $73.21 and touched a high of $171.20 over the same period. THC has an average intraday trading volume of 1.37 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.11%, -12.94%, and -6.00% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Tenet Healthcare Corp (NYSE: THC) shares accounts for 93.91% of the company’s 95.08M shares outstanding.
It has a market capitalization of $12.36B and a beta (3y monthly) value of 2.06. The stock’s trailing 12-month PE ratio is 4.16, while the earnings-per-share (ttm) stands at $31.26. The company has a PEG of 0.59 and a Quick Ratio of 1.52 with the debt-to-equity ratio at 3.36. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.40% over the week and 3.17% over the month.
Analysts forecast that Tenet Healthcare Corp (THC) will achieve an EPS of 2.8 for the current quarter, 2.96 for the next quarter and 10.98 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.48 while analysts give the company a high EPS estimate of 1.48. Comparatively, EPS for the current quarter was 2.68 a year ago. Earnings per share for the fiscal year are expected to increase by 62.20%, and 0.91% over the next financial year. EPS should shrink at an annualized rate of 7.10% over the next five years, compared to 40.40% over the past 5-year period.
Looking at the support for the THC, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on December 17, 2024, with the firm’s price target at $175. Goldman coverage for the Tenet Healthcare Corp (THC) stock in a research note released on December 16, 2024 offered a Neutral rating with a price target of $140. Wells Fargo was of a view on November 25, 2024 that the stock is Equal Weight, while Raymond James gave the stock Outperform rating on November 22, 2024, issuing a price target of $195. KeyBanc Capital Markets on their part issued Overweight rating on October 11, 2024.
